CLINICAL TRIALS PROFILE FOR BLEPHAMIDE
✉ Email this page to a colleague
All Clinical Trials for BLEPHAMIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02256969 ↗ | Intraductal Meibomian Gland Probing Trial | Completed | Joseph B. Ciolino, MD | Phase 4 | 2014-10-01 | In this research study, the investigators are looking at the effects of Meibomian Gland Probing (MGP) versus a sham (fake) procedure in patients with refractory MGD who have already tried traditional management with no success in resolving their clinical signs (as seen by their ophthalmologist) or their symptoms. The investigators are also evaluating the effects of using two (2) post-procedural medication treatments: Blephamide or GenTeal PM Night-Time to determine if treatment after the MGP procedure has an effect on its outcome. |
NCT02256969 ↗ | Intraductal Meibomian Gland Probing Trial | Completed | Massachusetts Eye and Ear Infirmary | Phase 4 | 2014-10-01 | In this research study, the investigators are looking at the effects of Meibomian Gland Probing (MGP) versus a sham (fake) procedure in patients with refractory MGD who have already tried traditional management with no success in resolving their clinical signs (as seen by their ophthalmologist) or their symptoms. The investigators are also evaluating the effects of using two (2) post-procedural medication treatments: Blephamide or GenTeal PM Night-Time to determine if treatment after the MGP procedure has an effect on its outcome. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BLEPHAMIDE
Condition Name
Clinical Trial Locations for BLEPHAMIDE
Trials by Country
Clinical Trial Progress for BLEPHAMIDE
Clinical Trial Phase
Clinical Trial Sponsors for BLEPHAMIDE
Sponsor Name